First Time Loading...
N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 24.93 CNY -1.89% Market Closed
Updated: May 17, 2024
Nanjing Vazyme Biotech Co Ltd
/
Cash Flow Statement
/
Cash from Operating Activities

Nanjing Vazyme Biotech Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanjing Vazyme Biotech Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
N
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Cash from Operating Activities
¥153m
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Operating Activities
-¥7.8B
CAGR 3-Years
-15%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Operating Activities
¥147.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Operating Activities
¥1.5B
CAGR 3-Years
49%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Operating Activities
¥5.8B
CAGR 3-Years
14%
CAGR 5-Years
134%
CAGR 10-Years
43%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Operating Activities
¥1.2B
CAGR 3-Years
57%
CAGR 5-Years
70%
CAGR 10-Years
N/A

See Also

What is Nanjing Vazyme Biotech Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
153m CNY

Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Cash from Operating Activities amounts to 153m CNY.

What is Nanjing Vazyme Biotech Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-42%

Over the last year, the Cash from Operating Activities growth was -79%. The average annual Cash from Operating Activities growth rates for Nanjing Vazyme Biotech Co Ltd have been -42% over the past three years .

ALPHA SPREAD
Join more than 137,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.